<VariationArchive RecordType="classified" VariationID="1326263" VariationName="Single allele" VariationType="Duplication" Accession="VCV001326263" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-11-29" MostRecentSubmission="2021-11-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1316587" VariationID="1326263">
      <GeneList>
        <Gene Symbol="OPHN1" FullName="oligophrenin 1" GeneID="4983" HGNC_ID="HGNC:8148" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="68042344" stop="68433841" display_start="68042344" display_stop="68433841" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="67262185" stop="67653298" display_start="67262185" display_stop="67653298" Strand="-" />
          </Location>
          <OMIM>300127</OMIM>
          <Haploinsufficiency last_evaluated="2023-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OPHN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-03-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OPHN1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" outerStart="67412300" innerStart="67412835" innerStop="67433704" outerStop="67434814" display_start="67412300" display_stop="67434814" />
      </Location>
      <FunctionalConsequence Value="decreased transcript level variant">
        <XRef ID="SO:0001541" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND X-linked intellectual disability-cerebellar hypoplasia syndrome" Accession="RCV001785447" Version="1">
        <ClassifiedConditionList TraitSetID="3162">
          <ClassifiedCondition DB="MedGen" ID="C1845366">X-linked intellectual disability-cerebellar hypoplasia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-11-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-29" MostRecentSubmission="2021-11-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3162" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2904" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 60</ElementValue>
                <XRef Type="MIM" ID="300486" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE</ElementValue>
                <XRef Type="MIM" ID="300486" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked intellectual disability-cerebellar hypoplasia syndrome</ElementValue>
                <XRef ID="MONDO:0010337" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRX60</ElementValue>
                <XRef Type="MIM" ID="300486" DB="OMIM" />
              </Symbol>
              <XRef ID="137831" DB="Orphanet" />
              <XRef ID="C1845366" DB="MedGen" />
              <XRef ID="MONDO:0010337" DB="MONDO" />
              <XRef Type="MIM" ID="300486" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3971915" SubmissionDate="2021-11-25" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="SUB10705428" submittedAssembly="GRCh37" title="SUB10705428" />
        <ClinVarAccession Accession="SCV002025778" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="Institute of Science, Banaras Hindu University" OrgID="508228" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Pathogenic variants in the Oligophrenin 1 gene (OPHN1) cause an X-linked intellectual disability syndrome with a phenotype typically consisting of cerebellar hypoplasia, ventriculomegaly, seizures, facial dysmorphism, speech delay and sometimes behavioral difficulties. We describe a male patient with global developmental delay, and cerebellar hypoplasia and other neuroanatomical findings suggestive of a Dandy-Walker malformation. The clinical pontocerebellar hypoplasia sequencing panel revealed a partial duplication from exon 7 to exon 15 in OPHN1, which was maternally inherited. PCR-Sanger sequencing of cDNA showed a truncating frameshift in the OPHN1 transcript. Further, transcript level analysis of OPHN1 showed a 75% reduction in the total expression in the patient in comparison to controls. Presumably this leads to a similar reduction in the level of OPHN1 protein resulting in the observed phenotype. This is the first report of a partial duplication of exons 7-15 in OPHN1 in a patient with strabismus, speech delay, dysmorphic facial features, epilepsy, an autism-like phenotype, and developmental delay.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>United States</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>The clinical pontocerebellar hypoplasia sequencing plus deletion/duplication analysis panel was performed at GeneDx, Inc (Gaithersburg, MD, USA) and interrogated the following genes: CASK, CHMP1A, CLP1, EXOSC3, OPHN1, RARS2, RELN, SEPSECS, TSEN2, TSEN34, TSEN54, TUBA1A, TUBA8, TUBB2B, TUBB3, VLDLR, VPS53, and VRK1. Targeted exons were enriched from genomic DNA by RNA probe capture using a custom Agilent SureSelect kit (Agilent Technologies, Santa Clara, CA, USA) to produce DNA libraries for next generation sequencing (NGS). The sequencing data were generated on an Illumina platform, and sequence variants were identified, filtered, and evaluated with a custom bioinformatics pipeline as previously described [Stosser et al., 2018]. Capillary sequencing was used to obtain sequence for regions where fewer than 15 reads were achieved by NGS. Copy number variations were also evaluated using custom exon-level array CGH (Agilent Technologies, Santa Clara, CA, USA) targeting most coding exons of the panel genes. Reporting threshold included pathogenic variants, likely pathogenic variants, and variants of uncertain significance. All reportable variants were confirmed by an orthogonal method.</Description>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Paired-end mapping</Attribute>
              </MethodAttribute>
              <MethodAttribute>
                <Attribute Type="TestName">pontocerebellar hypoplasia sequencing panel</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2021-11-23">GeneDx</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <Comment>The clinical pontocerebellar hypoplasia sequencing plus deletion/duplication analysis panel was performed at GeneDx, Inc (Gaithersburg, MD, USA) and interrogated the following genes: CASK, CHMP1A, CLP1, EXOSC3, OPHN1, RARS2, RELN, SEPSECS, TSEN2, TSEN34, TSEN54, TUBA1A, TUBA8, TUBB2B, TUBB3, VLDLR, VPS53, and VRK1. Targeted exons were enriched from genomic DNA by RNA probe capture using a custom Agilent SureSelect kit (Agilent Technologies, Santa Clara, CA, USA) to produce DNA libraries for next generation sequencing (NGS). The sequencing data were generated on an Illumina platform, and sequence variants were identified, filtered, and evaluated with a custom bioinformatics pipeline as previously described.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" innerStart="67412835" innerStop="67433704" outerStart="67412300" outerStop="67434814" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">exon 7 to exon 15 duplication</Name>
          </OtherNameList>
          <FunctionalConsequence Value="decreased transcript level variant">
            <XRef DB="Sequence Ontology" ID="SO:0001541" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0001541" />
          </FunctionalConsequence>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300486" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10705428</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3971915" TraitType="Disease" MappingType="XRef" MappingValue="300486" MappingRef="OMIM">
        <MedGen CUI="C1845366" Name="X-linked intellectual disability-cerebellar hypoplasia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

